Hotcopper spl. J K Fairley $1,272,084N J Baade. Hotcopper spl

 
J K Fairley $1,272,084N J BaadeHotcopper spl  38

Join the HotCopper ASX share market forum today for free. I am STILL inviting comment on SPL and their Zika proclamations, and how this is evidence of SPL’s long standing crumb throwing method. Hi folks SPL seems to have gone through a major change in the last 5 months (obviously because of recent news in that period) . Last edited by sarge17 : 19/09/20 SPL Price at posting: $1. Created with Sketch. Created with Sketch. SPL. 5¢. . Target our investor community with our suite of Hotcopper Advertising opportunities. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Share Step 1. And that is my opinion too but about SPL. 59pm 17/11/2023 ? HotCopper has news, discussion, prices and market data on SYRAH RESOURCES LIMITED. Charts. I constantly question why I continue to subject myself to the ongoing. International Markets. Created with Sketch. This extract caught my eye"The AstraZeneca programs involves $US124 million of milestones, about half of which are “relatively near”. . Melbourne, Australia; 16 March 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its second radiopharmaceutical candidate, DEP® HER2-lutetium, achieved potent and durable anticancer activity, with complete tumour regression, outperforming Herceptin® (trastuzumab) labelled with lutetium, in a human breast cancer model (BT474). . Additionally, three of the companies mentioned that have approved and marketed IO. Phillip Altman is a highly-respected and well-known Australian authority on clinical trials and drug regulatory affairs with more than 40 years of experience in designing, managing and reporting of clinical trials and in working with the Australian Therapeutic Goods Administration (TGA) in gaining new drug approvals. Created with Sketch. ASX - Short Term Trading. I know that Company's have to concentrate on the task at hand but an awareness of the World Economy is important. Forums. Jackie in the discussion talked about dealing with the tourist industry. Created with Sketch. ASX - Day Trading. Created with Sketch. I have today made my own enquiries with AstraZeneca directly on 1-877-240-9479 and they (Camellia) have confirmed that this trial is not yet recruiting and she also confirmed that the day recruitment starts the status on the website will be updated. AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. . 16,364,160. Search for Betafem BV, Fleurstat or Viraleze and you will often get competing products but no reference to what you searched for (that is the way Google works). ASX - By Stock. Created with Sketch. Created with Sketch. 38. HotCopper has news,. 12. Created with Sketch. Share It is VERY disappointing that a CEO, Chair and company secretary can still throw a Sky and Land logo onto a corporate presentation as an indication of a partnership even though after 6. Created with Sketch. Add SPL (ASX) to my watchlist (20min delay). . . “Who in at SPL made these commitments on timelines?” ~ @Joelsmith2452 CEO Jackie Fairley first told shareholders that the current Phase 2 DEP-Docetaxel trial would be complete by the end of CY2018. 5¢ STARPHARMA HOLDINGS LIMITED - Discussion. 0¢. 0¢. ASX - By Stock. Market . leaves 13+ million shares that were sold by someone else (maybe FIL or AG ??). Forums. In part it oversees accelerated research initiatives to develop responses to unmet needs. Charts. 26. . Created with Sketch. ASX - Day Trading. 11%. Perhaps they will today tomorrow. All IMO this highlights the problems with agreements where there is seemingly no min order quantity and obligation to advertise and promote the product. Join the HotCopper ASX share market forum today for free. 48. 50 or. We love cruising, but this multi billion dollar industry has effectively been shut down. ASX - By Stock. Commodities. Last updated 15. In summary, my observations about SPL are: Marketing - persistent. municipal. 0¢ STARPHARMA HOLDINGS LIMITED - Discussion. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Share I sometimes wonder if they actually work at Starpharma. ASX - By Stock. Created with Sketch. SPL. . 37 Sentiment: Buy Disclosure: Held. . It seems long-suffering retail. 00%. Target our investor community with our suite of Hotcopper Advertising. Hope that SPL starts to deliver on its promises. Last edited by antibotter : 13/11/23. ASX - By Stock. SPL has on multipleoccasions used COVID as an excuse for expanded timelines on active trails andto my understanding SPL has also been receiving support from the governmentduring COVID. I sold out of my position in SPL at that time precisely because of this. The latest Hotcopper Holdings [HOT] news, articles, data and analysis from The Australian Financial Review About this app. 3¢. Announcement on LinkedIn today from Prof David Owen that has left SPL after 15years as VP. 48. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Dec 14 (Reuters) - Starpharma Holdings Ltd (SPL) : VIRALEZE NASAL SPRAY REGISTERED IN INDONESIA PROGRESSING DISCUSSIONS WITH POTENTIAL DISTRIBUTION. Created with Sketch. 8985. The AGM has come and gone What did we learn from this meeting according to our attendee's who post on HotCopper forum When it comes to. I was hoping for. . 367026. Charts. ASX - Short Term Trading. Created with Sketch. HotCopper is an Australian stock market online chat forum that allows its users to discuss financial topics. All the case studies have already been touted by SPL in various ASX announcements and the only trial that is declared finished by Starpharma and scheduled for readouts is DEP Cabazitaxel and that isn't until in Q3 CY2023 ,. . 5¢. ASX - By Stock. Build your trading strategy and connect with. . Starpharma are 4+ years from their CRL for Vivagel and we really are none the wiser of what is going on apart from a snippet in the AGM presentation stating 'we. On the subject of upfront licence fees Bell Potter in one of their analyses on SPL several years ago gave estimates of the likely upfront fees at $15M for Dep Doc, $8M for Dep Cab & $30M for Dep Irin. HotCopper is Australia's largest free and independent stock market trading forum for. You should withdraw the statement. 63. Click for more information. * All the touted pending/expected deals with the Majors come to very little with the usual statement "in discussions"Created with Sketch. They not even have a license with SPL, just a basic research agreement. The only double standard I see is that if any employee in the real world repeatedly told their boss that a project would definitely be delivered, every year since 2018 and the project has still not been delivered in early 2023 then they would be ceremoniously SACKED. I recommend that everyone sees the below. Forums. Forums. I have no problem with the way SPL accessed the market initially but percieved issues over time and this may be one. . 7¢. 0¢. ASX - Short Term Trading. Join the HotCopper ASX share market forum today for free. No change of interest notification received. Once they think they can get AZD0466 to market they will pounce if our share price is less tan $2. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . It totally unrealistic that Merck will enter the clinic in 4-5 months. Market Cap $77. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Can you imagine. Come on SPL, complete these trials for the Companys sake, the shareholders sake and all the people out there suffering from these cancers. 57pm 13/11/2023 ? HotCopper has news, discussion, prices and market data on SUNRISE ENERGY METALS LIMITED. Advertise on HotCopper. 70 Sentiment: Sell Disclosure: Held Not only did AZ not announce completion of Phase 1 with stellar results, the commencement of Phase 2 and a big milestone payment to SPL as the pompom brigade were postulating, it was just interim Phase 1 results and dose escalation apparently continues. Ineffective deals and sloppy clinical trials and regulatory tactics might be able to be gloss over for years but over times it show in the bottom line. “If humans respond in a similar way, the benefits of treatment. Latest Posts | Join the HotCopper forum today for free, page-1. ASX - By Stock. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . The purpose of many of us working in pharmaceutical research and development whether within the industry or academia is to deliver medicines to improve the lives of patients around the world. Prior to the trial results being released SPL need to get on the front foot. Last updated 15. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . SPL have hit road blocks with many of their products. HotCopper has over 250,000 registered members, and more than 200,000 unique visitors every month and a huge 21 million monthly page impressions. It’s unlikely to happen, but personally I hope Rob Thomas and Jackie Fairley fall on their sword prior to the AGM. Latest Posts. Market . That won’t be a shock to. Join the HotCopper ASX share market forum today for free. Last updated 15. News: SPO Spotless Group To Be Removed From Official List Of ASX Ltd At Close Of Trading On 30 Aug. The matter has been adjourned to. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Disowned him really. 57. Created with Sketch. Last updated 15. Provide some keywords to assist in categorisation of your abstract. ASX - By Stock. 43pm 10/11/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. A new DFS upgrade has expanded operation capacity on-site the project from 15 gigawatt hour’s worth of battery production to 120GWh. Only 12 episodes made but so Iconic . And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Join the HotCopper ASX share market forum today for free. Share Interesting and positive early pre-clinical results. Last post JoeSalami. I think with SPL we are up to series 10 episode 100!!!! and I do laugh a lot mostly at posters naiviety On your part pretty poor form comparing such a classic comedy with such a tragic live comedy watched on the market everyday !!Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. 82%)And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat. I think this is the start of a trail that may lead somewhere in hopefully SPL offering shareholder clearer explainations and referenced articles / posters etc in announcements being on website and then later being unavaliable is a process across the ASX that has to be stopped. The last time was December 2018. $-0. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. A trader who used stock forum HotCopper to pump and dump about 20 penny stocks using 13 trading accounts has been given a jail term of 2½ years, but is being released immediately on a five-year. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 3. 0. m. This product was expected to produce rivers of. Created with Sketch. Join Australia’s largest community of ASX investors and share market enthusiasts in our free and independent stock market forum. There is potentially a multi-bagger upside if there was an exceptionally good news announcement. , Inc. ASX - Short Term Trading. ASX - Day Trading. ASX - Short Term Trading. ASX - Day TradingCreated with Sketch. HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. We would like to show you a description here but the site won’t allow us. The ASX is trying to crack down on many companies. Created with Sketch. 17112. 37. But the products were developed as proof of a saleable dendrimer product. Starpharma have so far been quite disappointing in the way it has commercialised products The Vivagel condom A dismal failure so far It had been approved. Advertise on HotCopper. Hi all, I think it would be in all of our best interests if each of us sent an email to SPL investor relations and voiced our concerns. 3¢ STARPHARMA HOLDINGS LIMITED - Discussion. I wonder if LLoyds are taking the pain on 50% off or if SPL rebating just to get volume and name in market ? LLoyds depending on agreemnet would usually just return stock IMO. " Indeed. Latest Posts. ASX - Day Trading. Market . All ETFs by Morningstar Ratings Morningstar Medalist Rating Gold. LEADING THE BATTERY METALS REVOLUTION. This is a charting thread for those interested in the movements of the SPL SP. ASX - General. but hey don't take my word for it, see for yourself in the official SPL ASX announcement dated 17th April 2023 You would think that somewhere SPL woudl have commented that TGA is awaiting data from UK trial. ASX - Short Term Trading. AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. Created with Sketch. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Created with Sketch. And it’s at least good to see that the ASX has demanded supplementary information from Starpharma on numerous occasions recently. With SPL we have entered a relatively short term period where things are going to develop into something serious. Application for quotation of securities - SPL. . 0¢. SPL Price at posting: 71. However, I think that maybe SPL is occasionally worth a swing trade gamble. I hope I'm wrong here. Created with Sketch. Some links within this article worth a scan too. Target our investor community with our suite of. 0¢ Sentiment: Buy. . . ASX - By Stock. 4¢. Discussion. and even when Big pharma are challenged legally and lose in court as in Johnson and Johnson bladder slings - its 20 years after the tort, 8 yrs fighting in court to then be waiting waiting waiting for compensation not for pain and suffering in VICTORIA just inconvenience costs such as buying pads and pain killers. So SPL did the one thing they could to challenge the TGA they sent it to adjudication and TGA were told Feb 22 - you must accept application as medical device and SPL announced to ASX in April 22 that their application was in. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 76. To me, that totally. . Meanwhile SPL seems to get into more schoolyard fights and then disagreements with Authority than company I have watched. New Zealand Dollar. The borders are now open Look forward to a positive outcome with new partnership agreements permeating from our team networking at ASCO. StarPharma Holdings Ltd. OR no reponse at all. ASX - Day TradingThe short position has been negligible in Starpharma since we go booted from the ASX300 and the shorts were able to cover a large portion of their position at rock bottom share prices in the re-balance. ASX - By Stock. There were 17,468,532 shares dumped on Monday 18/10 and as per M & G notice today only 4,359,271 shares were from M & G on Monday. Join the HotCopper ASX share. 00% 14. 83453. 0000. Target our investor community with our. The reason I loaded up in the year post the last agm was because we we falsely told that vivagel would would be launched in Q1. ASX - By Stock. ASX - Day TradingSo the share price of SPL rose up to a high of $2. 5 cents. It was fairly obvious to the market that a crap raise was coming, and the SP might rise on this last chance in a while being out of the way before SPL is well capitalised. Right size, can penetrate deep into tumour tissue, right architecture, hang around long enough to do the job, soluble so the. SUBMISSION STEPS. All that seems to happen is that new verses are sometimes added. . 56am 20/11/2023 ? HotCopper has news, discussion, prices and market data on MAGNIS ENERGY TECHNOLOGIES LTD. Created with Sketch. Volume. I just hope that Starpharma shareholders sit up and notice at how the leaders of our company (the Chairman and CEO). Share Great ad I think it will boom in Hong Kong under the Banitore Manning name, despite what the naysayers say Banitore have a big presence in China their manufacturing of health products is also in China I would imagine they have significant pull in China and other regions, In my opinion Viraleze is set to be a huge world product in tome. 19/09/23. 0¢. ASX - General. ASX - General. Everyone holding SPL shares should now realise that unless they can have a deal signed on at least one of the Dep candidates within 3 to 6 months with a substantial upfront payment then a CR will definately be on the cards. 6 MILLION HY LOSS FROM CONTINUING OPERATIONS. 0. ASX - Short Term Trading. Zeus Resources Limited is an Australia-based mineral exploration company. Then you have the obvious issues with distribution with Lloydsand possiblly really cheap deal with Vietnam let alone teh mysterious India ,. CEO knows it is all going. In summary, there appears to be a massive financial incentive ($7m per year) for SPL to keep turnover below $20m, until such time as sufficient progress has been made on all fronts for profitability to become a. Hey, "smart", I concur with your message. SPL Price at posting. It is because SPL has abrogated the marketing role to its distributors. Below are 3 charts showing the predictions for Starpharma's Price by End 2019. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Canadian Dollar. 22/9/2000 CSL $11. Click for more information. 30. . Advertise on HotCopper. Latest Posts. ASX - Day Trading So the share price of SPL rose up to a high of $2. rights. PEG-b-pHPMA-lactate: Docetaxel, microtubule inhibitor/hydrolytic linkerwaste of cash by the time spl manage to do anything with nasal spray covid will have a vaccine if there is one thing spl have deomstrated it is an inability to do anything in a timely fashion. 49M. 52 (16th Feb) on the back of the hype that surrounded the launch of VIRALEZE in UK/EU/WORLD. ASX - Day Trading. ASX - Day TradingMelbourne, Australia; 6 May 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that VIRALEZE™ antiviral nasal spray is now available for purchase by consumers in Europe via Starpharma’s webstore. 1541401. Click for more information. The usual suspects on Hotcopper were pumping the Hong Kong and Macau ’deal’ last year as a game changer and rivers of gold were going to flow across the border from China for Viraleze, apparently. Expanding claims in UK- hmmm it would be a gamble by SPL to choose to put up that option rather than continue as is as MHRA may have same questions TGA has got ( whatever exactly they are) that don't seem to be resolved. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. HotCopper has news, discussion, prices and market data on SOUTHERN CROSS PAYMENTS LTD. 47pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on NOVONIX LIMITED. 2327/7/2021 CSL $292. Created with Sketch. 5¢. . Share Interesting points John Some institutions might accept anything over $1. bc. . Latest Posts. Altech Batteries (ASX:ATC) has confirmed its Silumina Anodes project can be eight times larger than previously thought. And he still is Chairman or Director of SIX other companies. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. 24am 31/10/2023 ? Share Prices & Charts for STARPHARMA HOLDINGS LIMITED. 971M ! Add to my watchlist. It is, to me, incredibly frustrating that SPL releases a good report with great promise and income mentions yet the market response is LIMP with a rise of. Taking Cols scenario for a sting like buyout if the buyout price is higher than the highest price the company has reached there is no avenue for complaint. Join Australia’s largest community of ASX investors and share market enthusiasts in our free and independent stock market forum. All along, SPL have said that they may sell off this entire arm of the business, or in fact once the Dep oncology advances further, perhsps split SPL into different businesses on the asx or to be sold off as completely separate businesses. 70. 6. Created with Sketch. . Pre-clinical results from a DEP HER2-Lutetium breast cancer model (see link below) were released by SPL in March 2021 with no update or published advancement since this announcement, and no deal/licence forthcoming. Share It would be silly to be tight on cash. ASX - Short Term Trading. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Target our investor community. . It is a real eye opener and paints the Pharmaceutical Industry in a very bad light. It is now more than ever that SPL needs to communicate with the market and keep everyone informed of any updates, because the radio silence and smoke and mirrors approach is evidently NOT WORKING. 0. 5. As Waldemar Januszczak said when looking at the portrait of Mr & Mrs Andrews by Gainsborough "THERE IS SOMETHING GOING ON here". 6% downward extention down to (0. Imo HotCopper posters must have an. 40. $0. Share WOW! Exactly 2 years after the start of this trial and still: NONE OF THE PATIENTS MET THE FORMAL CRITERIA OF A RESPONSE This is according to AstraZeneca’s own data, which is exactly the same disappointing result they announced in the last update last year at the ASHA congress in the USA in Dec 2022. yet if one considers that the amount of millions of shares via option they. 25. SPL Price at posting: $1. any other information the entity wishes to notify to ASX about the cessation?The Performance Rights issued under an employee incentive scheme lapsed during the course of the quarter ended 30June 2023 include 519,053 Rights held by KMP, Nigel Baade, and 310,760 Rights held by non-KMPs. my apologies that I could not stay after the. Comments. ASX - By Stock. 57% 13. , page-2. A correctly formatted example follows: Title of my presentation for the conference. 70. ASX - General. I think SPL are very worried on what a potential class action could implicate. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). The latest Hotcopper Holdings [HOT] news, articles, data and analysis from The Australian Financial ReviewAbout this app. Canadian Dollar. 3. Although with SPL's track record an exceptionally good news announcement seems unlikely, it is within the realms of possibility - and this seems to be what makes SPL worth a gamble. A correctly formatted example follows: Title of my presentation for the conference. Investors and the ASX now have their eye on SPL like they normally would have on dodgy mining penny stocks.